Innovation Institut Curie & Gustave Roussy's spin-off, Aglaia Therapeutics, becomes Ribonexus and signs exclusive license agreement with Pierre Fabre on an innovative target in oncology 11/18/2021
Innovation 15 years of Carnot: Institut Curie celebrates 10 years of research partnerships and innovations in the fight against cancer 11/04/2021
Partnership Breakthrough immunotherapy project led by Biomunex Pharmaceuticals, with Institut Curie & GTP Bioways, receives grants close to €3 million 11/04/2021
Innovation Curie Cancer, partner of the 3rd edition of the Cell Therapy Innovation 360° Congress 10/29/2021
Innovation A new strategy in immunotherapy: Institut Curie applauds the fundraising achieved by its spin-off Egle Therapeutics 10/19/2021
Partnership Institut Curie & PEP-Therapy announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors 10/05/2021
Innovation Aglaia Therapeutics: a new start-up from Institut Curie & Gustave Roussy raises €4M to fight resistance to targeted therapies 09/24/2021